AGTX - Agentix Corp.
0.042
-0.007 -15.476%
Share volume: 40,000
Last Updated: 03-17-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$0.05
-0.01
-0.13%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 02-14-2024 | 11-18-2024 | 09-24-2024 | 11-18-2024 | 02-18-2025 | 08-22-2025 | 11-20-2025 | 02-17-2026 | |
| Assets | |||||||||
| Total Assets | 111.951 K | 106.372 K | 166.946 K | 169.960 K | 154.111 K | 4.412 K | 5.601 K | 6.396 K | |
| Current Assets | 111.951 K | 106.372 K | 166.946 K | 169.960 K | 154.111 K | 4.412 K | 5.601 K | 6.396 K | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.480 K | 6.535 K | 9.072 K | 6.345 K | 8.273 K | 4.412 K | 5.601 K | 6.396 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 111.951 K | 106.372 K | 166.946 K | 169.960 K | 154.111 K | 4.412 K | 5.601 K | 6.396 K | |
| Total liabilities | 2.958 M | 2.667 M | 2.893 M | 3.007 M | 3.071 M | 3.276 M | 3.424 M | 3.504 M | |
| Total current liabilities | 2.958 M | 2.667 M | 2.893 M | 3.007 M | 3.071 M | 3.276 M | 3.424 M | 3.504 M | |
| Accounts Payable | 2.836 M | 2.500 M | 2.695 M | 2.796 M | 2.824 M | 2.849 M | 2.971 M | 3.027 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -2.846 M | -2.600 M | -2.726 M | -2.877 M | -2.917 M | -3.272 M | -3.418 M | -3.498 M | |
| Common stock | 3.119 M | 3.342 M | 3.382 M | 3.342 M | 3.328 M | 3.328 M | 3.328 M | 3.328 M | |
| Retained earnings | -5.951 M | -5.954 M | -6.105 M | -6.196 M | -6.340 M | -6.707 M | -6.851 M | -6.930 M |